MODALITY.AI , INC

Medtech · Private

Automated digital speech assessment tool for monitoring speech decline in ALS patients

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Total capital: $2.3M

Federal grants: $2.3M; 3 awards · 2022–2024; Rank in peer group#46 of 53
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 3; 5 pending · first 2025; Rank in peer group#12 of 53

Capital timeline

Latest events

Jun 2024Federal grantHealth and Human S · Phase II · A digital tool for monitoring speech decline in ALS$976K
Jun 2023Federal grantHealth and Human S · Phase II · A digital tool for monitoring speech decline in ALS$998K
May 2022Federal grantHealth and Human S · Phase II · A digital tool for monitoring speech decline in ALS$333K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 53 peers

Line = median

Medtech · Software

Federal grantsBelow median
Granted patents#12 · top 23%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 8

Jan 13, 2026GrantedMultimodal Investigation of Speech, Text, Cognitive and Facial Video Features for Characterizing Depression With and Without MedicationUSPTOUS 12,521,051
Nov 13, 2025PendingSystems And Methods For The Detection Of Autism Based On Speech-based BiomarkersUSPTOApplication 18660816
Nov 13, 2025PendingSystems And Methods For Multilabel Text Classification For Automatic Labeling Of Patient Self-reportsUSPTOApplication 18658198

Show all 8 patent records

Multimodal Investigation of Speech, Text, Cognitive and Facial Video Features for Characterizing Depression With and Without MedicationJan 13, 2026 · US 12,521,051Granted
Systems And Methods For The Detection Of Autism Based On Speech-based BiomarkersNov 13, 2025 · Application 18660816Pending
Systems And Methods For Multilabel Text Classification For Automatic Labeling Of Patient Self-reportsNov 13, 2025 · Application 18658198Pending
Multimodal Metrics for Remote Monitoring of Condition ProgressionOct 14, 2025 · US 12,444,505Granted
Interpretable Index Score for Combining Multimodal Metrics for Remote Monitoring of Condition ProgressionSep 9, 2025 · US 12,412,668Granted
Multimodal Conversational Platform For Remote Patient Diagnosis And MonitoringJan 19, 2023 · Application 17508693Pending
Use Of Virtual Agent To Assess Psychological And Medical ConditionsMay 5, 2022 · Application 17471929Pending
System and Method to Estimate Responsiveness and Optimal Participant Sample Sizes for ALS Clinical Trials Using Digital Speech BiomarkersApplication 63551060Pending

OPSICLEAR LLCSimilar federal contract value in Medtech · null in contracts
ARCHE HEALTHCARE LLCSimilar federal contract value in Medtech · null in contracts
LIGHT RESEARCH, INC.Similar federal contract value in Medtech · null in contracts
PROSTHETIC DESIGN, INC.Similar federal contract value in Medtech · null in contracts
THE RESTFUL JAW CO LLCSimilar federal contract value in Medtech · null in contracts
TREADWELL CORPORATIONSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.